NCT06945081View on ClinicalTrials.gov

Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Wilson DiseaseD-Penicillamine
Interventions
OTHER

Preparation of forearm molds with SILFLO® silicone

Preparation of forearm molds with SILFLO® silicone (MONADERM, Monaco), CE-marked and already used routinely in dermocosmetics. These molds will, then, be analyzed.

Trial Locations (1)

42055

Hôpital Nord CHU de Saint-Étienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06945081 - Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity | Biotech Hunter | Biotech Hunter